Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients - Trial NCT06256198
Access comprehensive clinical trial information for NCT06256198 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Sepsis. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ain Shams University
Timeline & Enrollment
N/A
Feb 01, 2024
Jun 01, 2024
Primary Outcome
prediction of clinical outcome in ICU septic patients
Summary
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to
 infection, if not recognized early and managed promptly, it can lead to septic shock,
 multiple organ failure and death. Sepsis is associated with high mortality, and the early
 recognition of the signs of tissue hypo perfusion is crucial in its management.
 
 This prospective study was aimed to detect that PCO2 gap can be taken as a reliable
 prognostic tool in septic patients
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06256198
Non-Device Trial